Quote from VigiServe Admin on November 27, 2020, 2:26 PMOnline Reporting AE Reporting Form Vaccine AE Form Guidance for Industry_Post-marketing Vigilance Requirements for Therapeutic Products and CTGTP469 KB Guidance for Industry_Post-marketing Vigilance Requirements for Therapeutic Products and Cell, Tissue and Gene Therapy Products (Aug 2024) Report Via: Post: Adverse Event Management Unit Vigilance Branch Health Sciences Authority Health Products Regulation Group 11 Biopolis Way #11-03, Helios Singapore 138667 Tel: (65) 6866 1111 E-Mail: HSA_productsafety@hsa.gov.sg Fax: (65) 6478 9069 https://youtu.be/AH-cT2Mljy4 https://youtu.be/4II-UVEe3QU
Online Reporting
AE Reporting Form
Vaccine AE Form
Guidance for Industry_Post-marketing Vigilance Requirements for Therapeutic Products and CTGTP469 KB
Guidance for Industry_Post-marketing Vigilance Requirements for Therapeutic Products and Cell, Tissue and Gene Therapy Products (Aug 2024)
Report Via: Post:
Adverse Event Management Unit Vigilance Branch Health Sciences Authority Health Products Regulation Group 11 Biopolis Way #11-03, Helios Singapore 138667
Tel: (65) 6866 1111
E-Mail: HSA_productsafety@hsa.gov.sg
Fax: (65) 6478 9069
https://youtu.be/AH-cT2Mljy4
https://youtu.be/4II-UVEe3QU